TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance).

H H Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.